J9196 Insurance Policy Changes

HCPCS J9196 is officially defined as "Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg." HCPCS J9196 is referenced in 4 tracked payer policy changes from UnitedHealthcare, Florida Blue, and 2 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J9196 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.